BOPA Abstract deadline EXTENDED TO 9am Monday 10th August 2020

You spoke – we listened

The deadline for abstracts for this year’s virtual conference has been extended. Delegates are invited to present results of their clinical and technical work as a poster with some selected for oral presentation. The author/s should submit via the BOPA website by 9am Monday 10th August 2020. Abstracts will be reviewed and marked by the BOPA Audit and Research Sub-Committee, and chosen authors will be invited to display their poster for the duration of the conference, with the posters achieving high scores selected for oral presentation.

Selected abstracts will be published in a supplement to the Journal of Oncology Pharmacy Practice (JOPP), providing authors with a citation in a peer reviewed journal. The winning presentation will receive a prize worth £2,000 to attend an international conference.

Further information can be found on the abstract section of the website HERE.

Late Breaking Abstracts: This year we will allow delegates to submit late breaking abstracts. Abstracts relating to the Covid-19 pandemic will be considered for presentation by the research committee if completed work is submitted after the 10th August deadline. Please contact the A&R committee to request a late submission relating to Covid-19.

Latest News

By BOPA Research Subcommittee on 15th June 2026

Deadline EXTENDED: Abstract Submission for #BOPA2026

Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN   Deadline for Abstract Submission for the 29th Annual BOPA Conference 2026 has been EXTENDED! Don’t miss the…

Read article
By BOPA on 15th June 2026

The BOPA Training and Development Grant – BOPA Conference 2026

BOPA are offering (in collaboration with Gilead) 16 funded places to the BOPA 2026 Conference in London from 2-4th Oct 20265. Information can be found here – The BOPA Training and Development Grant…

Read article
By BOPA Education & Training Subcommittee on 12th June 2026

BOPA Publication – Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative 

Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative  The study explored factors influencing cancer pharmacists’ progression through…

Read article
By BOPA AI Cancer Advisory Group on 12th June 2026

BOPA AI CAG contribute to the National Commission into the Regulation of AI in Healthcare: research, engagement and call for evidence findings

Recently, the MHRA invited feedback from individuals and organisations on the regulation of AI in healthcare across the UK. The BOPA AI CAG responded to this call for evidence, and…

Read article